|
RNF144A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17492690524068E-13 |
| Normal-vs-Stage2 |
5.500400E-03 |
| Normal-vs-Stage3 |
2.43471909300297E-13 |
| Normal-vs-Stage4 |
3.09108294516136E-12 |
| Stage1-vs-Stage2 |
2.384600E-01 |
| Stage1-vs-Stage3 |
6.261600E-02 |
| Stage1-vs-Stage4 |
1.012420E-02 |
| Stage2-vs-Stage3 |
2.510300E-02 |
| Stage2-vs-Stage4 |
4.643900E-03 |
| Stage3-vs-Stage4 |
2.862800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.236830E-03 |
| Normal-vs-Asian |
2.54829999990491E-07 |
| Caucasian-vs-AfricanAmerican |
6.023400E-01 |
| Caucasian-vs-Asian |
7.189600E-01 |
| AfricanAmerican-vs-Asian |
5.022200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.58999538166927E-11 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
6.051800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.71356287334856E-12 |
| Normal-vs-Age(41-60Yrs) |
1.6574519534629E-12 |
| Normal-vs-Age(61-80Yrs) |
3.82200049386938E-10 |
| Normal-vs-Age(81-100Yrs) |
4.812400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.705200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.444000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.182600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.113000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.150200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.928800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.410030E-01 |
| Classical-VS-Follicular |
1.99684713209081E-12 |
| Classical-VS-Other |
6.485400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.36929999561275E-08 |
| Tall-VS-Other |
4.642400E-01 |
| Tall-VS-Normal |
2.46899944933432E-10 |
| Follicular-VS-Other |
2.541200E-01 |
| Follicular-VS-Normal |
1.426980E-01 |
| Other-VS-Normal |
1.563390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58799995375603E-09 |
| Normal-vs-N1 |
2.63470001371502E-09 |
| N0-vs-N1 |
6.016200E-02 |
|
|
